265 related articles for article (PubMed ID: 20203504)
21. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host.
Sokol H; Seksik P
Curr Opin Gastroenterol; 2010 Jul; 26(4):327-31. PubMed ID: 20445446
[TBL] [Abstract][Full Text] [Related]
22. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
Seksik P; Dray X; Sokol H; Marteau P
Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
[TBL] [Abstract][Full Text] [Related]
23. The gut microbiota and inflammatory bowel disease.
Matsuoka K; Kanai T
Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
Sartor RB
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
[TBL] [Abstract][Full Text] [Related]
25. [Inflammatory bowel disease: IBD].
Endo K; Shiga H; Kinouchi Y; Shimosegawa T
Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
[TBL] [Abstract][Full Text] [Related]
26. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
Duboc H; Rajca S; Rainteau D; Benarous D; Maubert MA; Quervain E; Thomas G; Barbu V; Humbert L; Despras G; Bridonneau C; Dumetz F; Grill JP; Masliah J; Beaugerie L; Cosnes J; Chazouillères O; Poupon R; Wolf C; Mallet JM; Langella P; Trugnan G; Sokol H; Seksik P
Gut; 2013 Apr; 62(4):531-9. PubMed ID: 22993202
[TBL] [Abstract][Full Text] [Related]
27. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
Reuter BK; Pizarro TT
Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
[TBL] [Abstract][Full Text] [Related]
28. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
Mielants H; Veys EM
Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
[TBL] [Abstract][Full Text] [Related]
29. Negative interactions with the microbiota: IBD.
Salzman NH; Bevins CL
Adv Exp Med Biol; 2008; 635():67-78. PubMed ID: 18841704
[TBL] [Abstract][Full Text] [Related]
30. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
31. Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity.
De Hertogh G; Aerssens J; de Hoogt R; Peeters P; Verhasselt P; Van Eyken P; Ectors N; Vermeire S; Rutgeerts P; Coulie B; Geboes K
J Pathol; 2006 Aug; 209(4):532-9. PubMed ID: 16739113
[TBL] [Abstract][Full Text] [Related]
32. Expression of Toll-like receptors in the intestinal mucosa of patients with inflammatory bowel disease.
Tanaka K
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):193-6. PubMed ID: 19072354
[TBL] [Abstract][Full Text] [Related]
33. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases.
Chassaing B; Darfeuille-Michaud A
Gastroenterology; 2011 May; 140(6):1720-28. PubMed ID: 21530738
[TBL] [Abstract][Full Text] [Related]
34. Innate immunity in inflammatory bowel disease: state of the art.
Hisamatsu T; Ogata H; Hibi T
Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
[TBL] [Abstract][Full Text] [Related]
35. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
36. Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases.
Liang J; Sha SM; Wu KC
J Dig Dis; 2014 Dec; 15(12):641-6. PubMed ID: 25389085
[TBL] [Abstract][Full Text] [Related]
37. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease.
Rose DJ; Venema K; Keshavarzian A; Hamaker BR
Br J Nutr; 2010 May; 103(10):1514-24. PubMed ID: 20021704
[TBL] [Abstract][Full Text] [Related]
38. Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism.
Haller D
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S6-9. PubMed ID: 20535026
[TBL] [Abstract][Full Text] [Related]
39. The genetics of inflammatory bowel disease.
Bonen DK; Cho JH
Gastroenterology; 2003 Feb; 124(2):521-36. PubMed ID: 12557156
[TBL] [Abstract][Full Text] [Related]
40. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Verbeke KA; Boesmans L; Boets E
Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
